Watson Pharmaceuticals, Inc. Key Employee Agreement (March 1st, 2007)
This Key Employee Agreement (Agreement) is entered into as of December 11, 2006 (the Effective Date), by and between Thomas Giordano (Executive) and Watson Pharmaceuticals, Inc. (the Company), a Nevada corporation.
Andrx – Contract (May 5th, 2004)
EXHIBIT 10.79 November 1, 2002 Mr. Thomas R. Giordano 621 Solar Isle Drive Ft. Lauderdale, FL 33301 Dear Mr. Giordano: I am very pleased to offer you a position at Andrx ("Andrx"), upon the following terms: (1) Position: Senior Vice President and Chief Information Officer (2) Reporting to: Richard J. Lane, Chief Executive Officer (3) Salary: $225,000 annually (4) Stock Options: Non-qualified stock options to purchase 25,000 shares of Andrx's common stock. Although the actual stock option grant, vesting schedule, and exercise price of these options will be determined by the Andrx board at their next meeting, we anticipate that these options will vest annually over a five year period of time. (5) Target Bonus: The